Thiard News@F4F

@newsen.bsky.social

4 days ago

New Study Reveals CSF Liquid Biopsy's Potential in Diagnosing Leptomeningeal Disease A recent study shows that CSF liquid biopsy could be a game changer in diagnosing leptomeningeal disease, addressing previous inconclusive findings.

New Study Reveals CSF Liquid Biopsy's Potential in Diagnosing Leptomeningeal Disease #USA #Chicago #Liquid_Biopsy #Belay_Diagnostics #Leptomeningeal_Disease

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

PanGIA Biotech's Innovative Study Utilizes Machine Learning for Prostate Cancer Detection via Urine-Based Biopsy PanGIA Biotech has released a groundbreaking study demonstrating a 97.8% sensitivity for detecting prostate cancer using machine learning with urine biopsies, emphasizing earlier diagnosis.

PanGIA Biotech's Innovative Study Utilizes Machine Learning for Prostate Cancer Detection via Urine-Based Biopsy #United_States #Liquid_Biopsy #Delray_Beach #Prostate_Cancer #PanGIA_Biotech

Thiard News@F4F

@newsen.bsky.social

1 month ago

VolitionRx Achieves Major Breakthrough in Liquid Biopsy with Over 99% Cancer DNA Purity VolitionRx Limited makes significant strides in liquid biopsy technology, achieving over 99% purity in isolating cancer-derived DNA, paving the way for early detection.

VolitionRx Achieves Major Breakthrough in Liquid Biopsy with Over 99% Cancer DNA Purity #United_States #Liquid_Biopsy #cancer_detection #VolitionRx #Henderson,_Nevada

Thiard News@F4F

@newsen.bsky.social

1 month ago

Significant Growth Expected in Exosome Diagnostic and Therapeutics Market by 2032 The Exosome Diagnostic and Therapeutics Market is projected to reach USD 401.70 million by 2032, fueled by advancements in liquid biopsy and precision medicine.

Significant Growth Expected in Exosome Diagnostic and Therapeutics Market by 2032 #None #Liquid_Biopsy #Precision_Medicine #Exosome_Diagnostics

Thiard News@F4F

@newsen.bsky.social

2 months ago

Revolutionizing Liquid Biopsy: nRichDX and Hamilton's New Automated System Explore the partnership between nRichDX and Hamilton that aims to enhance liquid biopsy sample preparation with powerful automation and unmatched yield.

Revolutionizing Liquid Biopsy: nRichDX and Hamilton's New Automated System #United_States #Liquid_Biopsy #Hamilton #Reno #nRichDX

Thiard News@F4F

@newsen.bsky.social

3 months ago

New Standards Introduced for Liquid Biopsy Tests Monitoring Cancer Recurrence The BLOODPAC Consortium has published a new document detailing standards for liquid biopsy tests in JCO Precision Oncology, aiming to enhance cancer care.

New Standards Introduced for Liquid Biopsy Tests Monitoring Cancer Recurrence #USA #Chicago #Liquid_Biopsy #Cancer_Recurrence #BLOODPAC

Thiard News@F4F

@newsen.bsky.social

3 months ago

BLOODPAC Sets New Standards for Liquid Biopsy Tests to Monitor Cancer Recurrence BLOODPAC has published new standards for liquid biopsy tests aimed at monitoring cancer recurrence. This framework enhances test validation and patient care.

BLOODPAC Sets New Standards for Liquid Biopsy Tests to Monitor Cancer Recurrence #USA #Chicago #Liquid_Biopsy #Cancer_Recurrence #BLOODPAC

Thiard News@F4F

@newsen.bsky.social

4 months ago

VolitionRx Unveils Groundbreaking Technique for Liquid Biopsy with 180-Fold Enrichment VolitionRx has introduced a revolutionary method to enhance liquid biopsy, achieving astounding 180-fold enrichment that could change cancer detection forever.

VolitionRx Unveils Groundbreaking Technique for Liquid Biopsy with 180-Fold Enrichment #United_States #Liquid_Biopsy #Henderson #VolitionRx #Capture-Seq

Thiard News@F4F

@newsen.bsky.social

4 months ago

GC Genome's Study Uncovers Key Confounders Affecting Cancer Signal Detection in Liquid Biopsy A new study by GC Genome reveals critical physiological factors influencing cfDNA signals, paving the way to enhance liquid biopsy accuracy.

GC Genome's Study Uncovers Key Confounders Affecting Cancer Signal Detection in Liquid Biopsy #South_Korea #Liquid_Biopsy #Yongin #cancer_detection #GC_Genome

Thiard News@F4F

@newsen.bsky.social

4 months ago

Pillar Biosciences and AstraZeneca Enhance Liquid Biopsy Accessibility in China Pillar Biosciences and AstraZeneca have announced an expansion of their liquid biopsy partnership in China, enhancing access to genomic insights for cancer patients.

Pillar Biosciences and AstraZeneca Enhance Liquid Biopsy Accessibility in China #China #Shanghai #AstraZeneca #Liquid_Biopsy #Pillar_Biosciences

Thiard News@F4F

@newsen.bsky.social

6 months ago

Wobble Genomics Unveils Innovative Liquid Biopsy Technology at ESMO 2025 Wobble Genomics showcased groundbreaking advancements in cancer diagnostics at ESMO 2025, featuring a sensitive liquid biopsy platform for RNA detection.

Wobble Genomics Unveils Innovative Liquid Biopsy Technology at ESMO 2025 #United_Kingdom #Cancer_Diagnosis #Liquid_Biopsy #Edinburgh #Wobble_Genomics

Thiard News@F4F

@newsen.bsky.social

6 months ago

A.D.A.M. Innovations and SOPHiA GENETICS Partner to Enhance Liquid Biopsy Testing in Japan A.D.A.M. Innovations and SOPHiA GENETICS are collaborating to promote liquid biopsy testing and companion diagnostics for precision oncology in Japan, enhancing patient care.

A.D.A.M. Innovations and SOPHiA GENETICS Partner to Enhance Liquid Biopsy Testing in Japan #Japan #Tokyo #Liquid_Biopsy #SOPHiA_GENETICS #ADAM_Innovations

Thiard News@F4F

@newsen.bsky.social

6 months ago

A.D.A.M. Innovations and SOPHiA GENETICS Unite to Revolutionize Liquid Biopsy Testing in Japan A.D.A.M. Innovations and SOPHiA GENETICS collaborate to enhance liquid biopsy testing and precision oncology in Japan, making advanced diagnostics accessible.

A.D.A.M. Innovations and SOPHiA GENETICS Unite to Revolutionize Liquid Biopsy Testing in Japan #Japan #Tokyo #Liquid_Biopsy #SOPHiA_GENETICS #ADAM_Innovations

Thiard News@F4F

@newsen.bsky.social

6 months ago

Advancing Precision Oncology: A.D.A.M. Innovations Teams Up with SOPHiA GENETICS for Liquid Biopsy Testing A.D.A.M. Innovations and SOPHiA GENETICS join forces to enhance liquid biopsy testing for personalized cancer care in Japan, utilizing advanced AI technology.

Advancing Precision Oncology: A.D.A.M. Innovations Teams Up with SOPHiA GENETICS for Liquid Biopsy Testing #Japan #Tokyo #Liquid_Biopsy #SOPHiA_GENETICS #A.D.A.M._Innovations

Thiard News@F4F

@newsen.bsky.social

6 months ago

AccuGenomics and 1Cell.Ai Join Forces to Advance Liquid Biopsy Testing in Asia A new partnership between AccuGenomics and 1Cell.Ai aims to enhance liquid biopsy testing across Asia, expanding to the U.S. in the future.

AccuGenomics and 1Cell.Ai Join Forces to Advance Liquid Biopsy Testing in Asia #United_States #Liquid_Biopsy #Wilmington #1Cell.Ai #AccuGenomics

Thiard News@F4F

@newsen.bsky.social

6 months ago

Myriad Genetics and SOPHiA GENETICS Collaborate on Liquid Biopsy Diagnostics Myriad Genetics partners with SOPHiA GENETICS to create a groundbreaking liquid biopsy companion diagnostic test, enhancing cancer care worldwide.

Myriad Genetics and SOPHiA GENETICS Collaborate on Liquid Biopsy Diagnostics #USA #Liquid_Biopsy #Salt_Lake_City #SOPHiA_GENETICS #Myriad_Genetics

Thiard News@F4F

@newsen.bsky.social

7 months ago

Liquid Biopsy Market Growth Fueled by Rising Cancer Rates and Non-Invasive Tests The liquid biopsy market is projected to reach USD 30.65 billion by 2035, with a CAGR of 9.41%, driven by increasing cancer prevalence and demand for non-invasive diagnostics.

Liquid Biopsy Market Growth Fueled by Rising Cancer Rates and Non-Invasive Tests #None #Liquid_Biopsy #Cancer_Diagnostics #Non-Invasive_Testing

Thiard News@F4F

@newsen.bsky.social

7 months ago

BillionToOne Unveils Northstar Select® with Exceptional Sensitivity in Oncology Testing BillionToOne's Northstar Select® has shown superior sensitivity in genomic profiling when tested against existing assays, providing better insights for cancer treatment.

BillionToOne Unveils Northstar Select® with Exceptional Sensitivity in Oncology Testing #United_States #Liquid_Biopsy #Menlo_Park #BillionToOne #Northstar_Select

Thiard News@F4F

@newsen.bsky.social

8 months ago

Liquid Biopsy Market Forecast to Reach $7.05 Billion by 2030 Driven by Increasing Cancer Incidences The liquid biopsy market is projected to grow to $7.05 billion by 2030. This growth is driven by rising cancer cases and advancements in diagnostic technologies.

Liquid Biopsy Market Forecast to Reach $7.05 Billion by 2030 Driven by Increasing Cancer Incidences #None #Liquid_Biopsy #cancer_detection #NGS_Technology

Thiard News@F4F

@newsen.bsky.social

8 months ago

LuminoDx to Showcase Cutting-Edge HepatoTrack at World Transplant Congress LuminoDx is set to present HepatoTrack, a pioneering liquid biopsy test for liver transplant rejection at the World Transplant Congress in San Francisco.

LuminoDx to Showcase Cutting-Edge HepatoTrack at World Transplant Congress #USA #San_Francisco #Liquid_Biopsy #LuminoDx #HepatoTrack

Thiard News@F4F

@newsen.bsky.social

9 months ago

Genomill Health Unveils Bridge Capture™ Technology for Revolutionary Colorectal Cancer Liquid Biopsy Genomill Health's innovative Bridge Capture™ technology demonstrates high sensitivity in detecting colorectal cancer mutations through liquid biopsy, crucial for future applications.

Genomill Health Unveils Bridge Capture™ Technology for Revolutionary Colorectal Cancer Liquid Biopsy #USA #Liquid_Biopsy #Turku #Genomill_Health #Bridge_Capture

Thiard News@F4F

@newsen.bsky.social

9 months ago

Genomill Health's Bridge Capture™: A Breakthrough in Liquid Biopsy for Colorectal Cancer Detection Genomill Health has unveiled its Bridge Capture™ technology, which promises to enhance the sensitivity and scalability of liquid biopsy tests for colorectal cancer, enabling better patient monitoring.

Genomill Health's Bridge Capture™: A Breakthrough in Liquid Biopsy for Colorectal Cancer Detection #Finland #Liquid_Biopsy #Turku #Genomill_Health #Bridge_Capture

Thiard News@F4F

@newsen.bsky.social

9 months ago

Genomill Health's Bridge Capture™: A Breakthrough in Liquid Biopsy for Colorectal Cancer Discover how Genomill Health's innovative Bridge Capture™ technology offers a scalable, sensitive, and cost-effective solution for liquid biopsies in colorectal cancer monitoring.

Genomill Health's Bridge Capture™: A Breakthrough in Liquid Biopsy for Colorectal Cancer #USA #Liquid_Biopsy #Turku #Genomill #Bridge_Capture™

Thiard News@F4F

@newsen.bsky.social

10 months ago

Florida Cancer Specialists Introduces Innovative Liquid Biopsy Technology for Cancer Detection Florida Cancer Specialists has launched a liquid biopsy, providing a breakthrough in cancer detection through a simple blood test, enhancing patient care and treatment strategies.

Florida Cancer Specialists Introduces Innovative Liquid Biopsy Technology for Cancer Detection #United_States #Liquid_Biopsy #Florida_Cancer_Specialists #Fort_Myers #Precision_Oncology

Thiard News@F4F

@newsen.bsky.social

11 months ago

BillionToOne Unveils Groundbreaking Findings at Upcoming AACR 2025 Meeting BillionToOne is set to showcase its cutting-edge liquid biopsy technologies at the AACR Annual Meeting 2025, promising advances in cancer diagnostics.

BillionToOne Unveils Groundbreaking Findings at Upcoming AACR 2025 Meeting #United_States #Chicago #Liquid_Biopsy #BillionToOne #AACR

Thiard News@F4F

@newsen.bsky.social

1 year ago

Precision for Medicine Unveils Partnership with SOPHiA GENETICS to Enhance Biopharma Services Precision for Medicine has teamed up with SOPHiA GENETICS to boost biopharma service offerings, enhancing drug development with innovative technology.

Precision for Medicine Unveils Partnership with SOPHiA GENETICS to Enhance Biopharma Services #USA #Bethesda #Liquid_Biopsy #SOPHiA_GENETICS #Precision_for_Medicine

Thiard News@F4F

@newsen.bsky.social

1 year ago

Rarecells Inc. Welcomes Dr. Neil Kurtz as New Board Member to Enhance Leadership Team Rarecells Inc. has appointed Dr. Neil Kurtz, a prominent figure in healthcare entrepreneurship, to its Board of Directors, strengthening its mission.

Rarecells Inc. Welcomes Dr. Neil Kurtz as New Board Member to Enhance Leadership Team #United_States #New_York #Liquid_Biopsy #Rarecells_Inc. #Dr._Neil_Kurtz

Thiard News@F4F

@newsen.bsky.social

1 year ago

Innovative Collaboration Between Tethis and Sheba Medical Center to Enhance AI-Powered Liquid Biopsy for Rectal Cancer Tethis S.p.A. and Sheba Medical Center join forces to advance the use of AI-driven liquid biopsy technology in rectal cancer treatment, aiming for precision medicine breakthroughs.

Innovative Collaboration Between Tethis and Sheba Medical Center to Enhance AI-Powered Liquid Biopsy for Rectal Cancer #Israel #Liquid_Biopsy #Tethis #Sheba_Medical #Tel_Hashomer

Thiard News@F4F

@newsen.bsky.social

1 year ago

SOPHiA GENETICS Revolutionizes Liquid Biopsy Testing with MSK-ACCESS® Adoption SOPHiA GENETICS' MSK-ACCESS® for liquid biopsy testing gains traction globally, marking a significant advancement in oncology research and patient care.

SOPHiA GENETICS Revolutionizes Liquid Biopsy Testing with MSK-ACCESS® Adoption #USA #Boston #Liquid_Biopsy #SOPHiA_GENETICS #MSK-ACCESS

Thiard News@F4F

@newsen.bsky.social

1 year ago

Senseera Secures $7.1 Million Funding to Transform Liquid Biopsy Diagnostics Senseera has successfully closed a $7.1 million seed funding round, led by Lightspeed Venture Partners, to enhance its innovative liquid biopsy technology.

Senseera Secures $7.1 Million Funding to Transform Liquid Biopsy Diagnostics #Israel #Jerusalem #Liquid_Biopsy #Lightspeed #Senseera